Malcolm B Perry

Title: Innovations of Malcolm B Perry

Introduction

Malcolm B Perry is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of immunology, particularly in the development of methods for distinguishing between brucellosis infections and vaccinated cattle. With a total of four patents to his name, Perry's work has had a meaningful impact on veterinary medicine.

Latest Patents

One of his latest patents involves immunoassays for discriminating between brucellosis infections and vaccinated cattle. This method utilizes a purified polysaccharide containing 4,6-dideoxy-4-acylamido-D-mannopyranosyl units obtained from Brucella abortus or cross-reacting organisms. The innovation results in improved differentiation between vaccinated and infected animals. Additionally, he has developed antigenic polysaccharides specific to Brucella abortus and Yersinia enterocolitica serotype 0:9. These antigens can be chemically modified and are suitable for use in immunoassays such as ELISA and RIA.

Career Highlights

Throughout his career, Malcolm B Perry has worked with prominent organizations, including Canadian Patents & Development Ltd. and the National Research Council of Canada. His expertise in immunology and patent development has positioned him as a key figure in his field.

Collaborations

Perry has collaborated with notable individuals such as David R Bundle and John Walter Cherwonogrodzky. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

Malcolm B Perry's contributions to immunology and his innovative patents demonstrate his commitment to advancing veterinary medicine. His work continues to influence the field and improve diagnostic methods for brucellosis.